Global X标普500天主教价值股ETF CATH 深 沪
交易中 06-15 11:30:08 美东时间
89.94
+1.570
+1.78%
华盛通- 最 高89.94
- 今 开89.75
- 成交量 4508股
- 最 低 89.74
- 昨 收 88.3703
- 总市值 12.57亿
- 52周最高 90.68
- 市盈率 静 --
- 换手率 0.03%
- 52周最低 71.722
- 委 比 -29.91%
- 总股本 1397.95万
- 历史最高 90.68
- 量 比 0.48
- 振 幅 0.23%
- 历史最低 18.3857
- 每 手 1
- 风险率 4.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review
BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review June 11 (Reuters) - Imricor Medical Systems, Inc IMR.AX : SUBMISSION OF THE THIRD PMA MODULE TO THE US FDA FOR REVIEW SUBMISSION INCLUDES VISION-MR ABLATION CATHETER 2, RF-5000 GENERATOR, RF-5000 TUBING SET Further
06-11 09:28
FACTBOX-Airlines resume some Middle East flights but disruption continues
FACTBOX-Airlines resume some Middle East flights but disruption continues Updates Air France-KLM details June 2 (Reuters) - Airlines are gradually restoring some flights to the Middle East as regional carriers rebuild schedules after war-related disruption, though the conflict continues to disrupt w
06-02 19:51
Transcript: HeartFlow Q1 2026 Earnings Conference Call
HeartFlow (NASDAQ:HTFL) released first-quarter financial results and hosted an ...
05-15 05:44
CorMedix Q1 results beat on Defencath sales, raises outlook
CorMedix Q1 results beat on Defencath sales, raises outlook Overview US biopharma firm's Q1 revenue rose sharply, beating analyst expectations Adjusted EPS for Q1 beat analyst expectations Company raised full-year 2026 revenue and adjusted EBITDA guidance Outlook CorMedix raises 2026 net revenue gui
05-14 19:40
BRIEF-Cathay Financial Launches Long-Term Strategic Cooperation With OpenAI
BRIEF-Cathay Financial Launches Long-Term Strategic Cooperation With OpenAI TAIPEI, April 7 (Reuters) - Cathay Financial Holding Co Ltd 2882.TW said in a statement on Tuesday, LAUNCHES LONG-TERM STRATEGIC COOPERATION WITH OPENAI OPENAI PARTNERSHIP WILL STRENGTHEN OUR FOUNDATIONS IN AI RESEARCH, CORP
04-07 13:58
BRIEF-Catheter Precision Reports 2025 Results And Updates On Strategic Expansion
BRIEF-Catheter Precision Reports 2025 Results And Updates On Strategic Expansion Catheter Precision Inc VTAK.A : CATHETER PRECISION REPORTS 2025 RESULTS AND UPDATES ON STRATEGIC EXPANSION Source text: ID:nGNX7ddvKW Further company coverage: VTAK.A
03-31 20:48
FACTBOX-Price hikes, outlook cuts - What airlines are doing as fuel costs surge
FACTBOX-Price hikes, outlook cuts - What airlines are doing as fuel costs surge Updates SAS, adds Akasa Air, American Airlines, Frontier Airlines, IndiGo March 18 (Reuters) - A surge in jet fuel prices, driven by the U.S.-Israeli war on Iran , has upended the global aviation industry, prompting air
03-18 21:35
Airlines cancel more flights as Middle East conflict escalates
Airlines cancel more flights as Middle East conflict escalates Updates Cathay Pacific entry March 18 (Reuters) - Global air travel remains severely disrupted after the war in Iran forced the closure of key Middle Eastern hubs including Dubai, Doha and Abu Dhabi, stranding tens of thousands of passen
03-17 18:57
BRIEF-BioCardia Announces Pre-Submission Approval Package For Helix Transendocardial Delivery Catheter Accepted By FDA
BRIEF-BioCardia Announces Pre-Submission Approval Package For Helix Transendocardial Delivery Catheter Accepted By FDA March 17 (Reuters) - BioCardia Inc BCDA.O : BIOCARDIA ANNOUNCES PRE-SUBMISSION APPROVAL PACKAGE FOR HELIX TRANSENDOCARDIAL DELIVERY CATHETER ACCEPTED BY FDA Source text: ID:nGNX1hL3
03-17 18:18
Pharmaceutical firm CorMedix misses Q4 profit expectations, reiterates 2026 revenue forecast
Pharmaceutical firm CorMedix misses Q4 profit expectations, reiterates 2026 revenue forecast Overview Biopharmaceutical firm's Q4 2025 net revenue was $128.6 mln, driven by DefenCath sales Q4 net income of $14 mln missed analyst expectations Company announced $75 mln share repurchase program Outlook
03-05 20:39
